You are here: HomeSolutionsIndustriesConsumer Health
print my pages

Country Report

Consumer Health in Canada

Mar 2011

Price: $2,400

About this Report

About this Report

Delivery method: instant download
Report format: PDF doc_pdf.png (download a sample)
Market statistics: Excel workbook doc_excel_table.png (download a sample)

Overview

Discover the latest market trends and uncover sources of future market growth for the Consumer Health industry in Canada with research from Euromonitor's team of in-country analysts.

Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.

If you're in the Consumer Health industry in Canada, our research will save you time and money while empowering you to make informed, profitable decisions.

When you purchase this report, you also get the data and the content from these category reports in Canada for free:

The Consumer Health in Canada market research report includes:

  • Analysis of key supply-side and demand trends
  • Detailed segmentation of international and local products
  • Historic volumes and values, company and brand market shares
  • Five year forecasts of market trends and market growth  
  • Robust and transparent market research methodology, conducted in-country

Our market research reports answer questions such as:

  • What is the market size of Consumer Health in Canada?
  • What are the major brands in Canada?
  • What are the main trends in OTC Healthcare?

Why buy this report?

  • Gain competitive intelligence about market leaders
  • Track key industry trends, opportunities and threats
  • Inform your marketing, brand, strategy and market development, sales and supply functions

This industry report originates from Passport, our Consumer Health market research database.

Sample Analysis

EXECUTIVE SUMMARY

Positive market growth sustained in 2010 despite slow economic recovery

Growth in overall retail sales of consumer health products remained relatively strong despite signs of slower-than-expected economic recovery. Rising demand for consumer health products is largely bolstered by the ageing Canadian population, combined with growing incidence of various health ailments associated with poor diet and unhealthy lifestyles amongst Canadians of all ages. Furthermore, the increasing presence of private label in most categories has gained a significant level of consumer demand, as Canadians increasingly seek more affordable products during times of economic and financial uncertainties.

Rapidly ageing population in Canada a key driver of consumer health sales

The population in Canada continues to age at a rapid rate, with the first cohort of baby boomers expected to reach the retirement age of 65 in 2011. The rising proportion of senior Canadians has had a significant impact on the cost of health care services as an increasing number of people experience a wide range of age-related health conditions, including osteoporosis, rheumatoid arthritis, vision and hearing impairment, muscle pain and back pain, as well as digestive tract problems. Moreover, the rapid ageing of the Canadian population has resulted in declining levels of essential nutrients and minerals, resulting in deterioration of its physical and mental health conditions. Consequently, the rising rate of illness and various age-related ailments has triggered demand for a wide range of over-the-counter (OTC) consumer health products.

International manufacturers continue to lead sales in Canada

International or global manufacturers continued to dominate consumer health in Canada. With ongoing product innovation and marketing campaigns, as well as a number of acquisitions, shares of global manufacturers further increased during the review period. Whilst international manufacturers occupy leadership positions in OTC products and weight management, vitamins and dietary supplements continues to be led by Canada’s leading domestic manufacturer, CE Jamieson & Co Ltd.

Drugstores dominate retail distribution

Parapharmacies/drugstores remained the leading retailers within the Canadian consumer health industry. Although the public healthcare system offers coverage for a number of treatments, such as dental care, most health problems experienced on a daily or regular basis are self-treated or self-medicated. This has resulted in the growing trend towards use of consumer health products. Given that professional consultation with, and treatment by, medical doctors are costly, Canadians generally consider local pharmacists and nutritionists as the best source for advice regarding the safety and efficacy of products, which has resulted in the leadership of parapharmacies/drugstores in all categories of consumer health.

Strong market growth projected over 2010-2015 forecast period

Over the forecast period, retail sales of consumer health products are projected to show strong growth. Canada’s rapidly ageing population, growing consumer awareness of health risks associated with poor diet and lack of physical activities, and the growing presence of private label products offering competitive prices in certain categories will all have a positive impact on sales. Furthermore, growing public concerns regarding overdoses of prescription drugs as well as increasing availability of generic variants will drive demand for consumer health products.

Table of Contents

Table of Contents

Consumer Health in Canada - Industry Overview

EXECUTIVE SUMMARY

Positive market growth sustained in 2010 despite slow economic recovery

Rapidly ageing population in Canada a key driver of consumer health sales

International manufacturers continue to lead sales in Canada

Drugstores dominate retail distribution

Strong market growth projected over 2010-2015 forecast period

KEY TRENDS AND DEVELOPMENTS

Economic and financial uncertainties help shares of private label

Ageing population increases rate of injuries and other illnesses in Canada

Aggressive marketing bolsters shares of global manufacturers in consumer health

Pharmacists and nutritionists become key players in consumer decisions

Natural health products face additional regulatory challenges

MARKET INDICATORS

  • Table 1 Consumer Expenditure on Health Goods and Medical Services 2005-2010
  • Table 2 Life Expectancy at Birth 2005-2010

MARKET DATA

  • Table 3 Sales of Consumer Health by Category: Value 2005-2010
  • Table 4 Sales of Consumer Health by Category: % Value Growth 2005-2010
  • Table 5 Consumer Health Company Shares by Value 2006-2010
  • Table 6 Consumer Health Brand Shares by Value 2007-2010
  • Table 7 Penetration of Private Label by Category 2005-2010
  • Table 8 Sales of Consumer Health by Distribution Format: % Analysis 2005-2010
  • Table 9 Sales of Consumer Health by Category and Distribution Format: % Analysis 2010
  • Table 10 Forecast Sales of Consumer Health by Category: Value 2010-2015
  • Table 11 Forecast Sales of Consumer Health by Category: % Value Growth 2010-2015

APPENDIX

OTC Registration and Classification

Vitamins and dietary supplements registration and classification

Self-medication/self-care and preventative medicine

Switches

  • Summary 1 OTC Healthcare Switches 2008-2010

DEFINITIONS

  • Summary 2 Research Sources

Consumer Health in Canada - Company Profiles

CE Jamieson & Co Ltd - Consumer Health - Canada

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 4 CE Jamieson & Co Ltd: Competitive Position 2010

Church & Dwight Canada Corp - Consumer Health - Canada

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 6 Church & Dwight Canada Corp: Competitive Position 2010

Prestige Brands Holdings Inc - Consumer Health - Canada

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 9 Prestige Brands Holdings, Inc: Competitive Position 2010

Swiss Herbal Remedies Ltd - Consumer Health - Canada

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 11 Swiss Herbal Remedies Ltd: Competitive Position 2010

Teva Canada Ltd - Consumer Health - Canada

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

Adult Mouth Care in Canada - Category Analysis

HEADLINES

TRENDS

  • In 2010, value sales of adult mouth care products grew moderately by 2%, reaching C$4 million in current value terms. Growth in demand for adult mouth care slowed down over the last few years of the review period, given that oral hygiene standards are generally good amongst Canadians and patients generally prefer to seek professional help, if needed. Canadian Health Measures Surveys conducted regularly by Statistics Canada indicate that Canadians, in general, have very good oral health with approximately 75% of the population visiting a dental professional every year and two thirds not needing any dental treatment. Furthermore, Canadians have demonstrated good preventive behaviours, such as 73% reporting brushing twice a day and 28% flossing at least five times a week.

SWITCHES

COMPETITIVE LANDSCAPE

  • Church & Dwight Canada Corporation remains the leader of adult mouth care products, with a category value share of 23% in 2010. Church & Dwight Canada Corporation was established in 1904 as a division of Church and Dwight Co. Ltd, focusing on manufacturing and distribution of household and personal care products. Its leading mouth care brand in Canada is Orajel, a well-established and trusted brand for oral health.

PROSPECTS

  • Over the forecast period, retail sales of adult mouth care products are projected to grow at a CAGR of 2%, reaching C$4 million in 2015. Growth will likely continue to slow down, given high oral hygiene standards in Canada and general preference for professional assistance when needed. However, the ability of OTC adult mouth care products to provide immediate and targeted relief from oral pain will continue to drive consumer demand.

CATEGORY DATA

  • Table 12 Sales of Adult Mouth Care: Value 2005-2010
  • Table 13 Sales of Adult Mouth Care: % Value Growth 2005-2010
  • Table 14 Adult Mouth Care Company Shares by Value 2006-2010
  • Table 15 Adult Mouth Care Brand Shares by Value 2007-2010
  • Table 16 Forecast Sales of Adult Mouth Care: Value 2010-2015
  • Table 17 Forecast Sales of Adult Mouth Care: % Value Growth 2010-2015

Analgesics in Canada - Category Analysis

HEADLINES

TRENDS

  • Sales of analgesics continued to show strong growth of 4% in 2010, reaching C$766 million in current value terms. Growth was largely driven by Canada’s rapidly ageing population as seniors increasingly experience muscle and joint pain throughout the ageing process. Furthermore, growing trend towards more active and hectic lifestyles amongst Canadians has led to rising incidence of muscle pain and injuries and headaches, increasing use of analgesics for immediate pain relief.

SWITCHES

COMPETITIVE LANDSCAPE

  • Wyeth Consumer Health Inc remained the leading manufacturer of analgesics in Canada, with a value share of 29% in 2010. The company’s leading position was mainly due to the enduring popularity of systemic analgesics brands Advil (ibuprofen) and Robaxacet (combination products). Both brands are heavily advertised, particularly on Canadian TV channels. Advil is positioned as being suitable for the relief of everyday aches and pains, including headaches, dental and arthritis pain, muscle pain and back pain. In particular, it is marketed as a solution for flu sufferers, since it not only relieves aches and pains but can also help to reduce fever. In 2010, Advil led sales of ibuprofen with a value share of 64%. Robaxacet is known to offer rapid pain relief with the added benefit of muscle relaxation, which makes it a popular choice amongst those experiencing age-related aches and pains. Robaxacet dominated the combination analgesics products category in 2010 with a value share of 55%.

PROSPECTS

  • Over the forecast period, retail sales of analgesics are projected to grow at a CAGR of 2%, reaching C$853 million by 2015. The ageing of Canada’s population, combined with growing trend towards more active lifestyles amongst consumers, will likely raise occurrence of body pain (ie muscle, back, headache), driving up the need for OTC analgesics.

CATEGORY DATA

  • Table 18 Sales of Analgesics by Category: Value 2005-2010
  • Table 19 Sales of Analgesics by Category: % Value Growth 2005-2010
  • Table 20 Topical Analgesics/Anaesthetic by Format: % Value Breakdown 2005-2010
  • Table 21 Analgesics Company Shares by Value 2006-2010
  • Table 22 Analgesics Brand Shares by Value 2007-2010
  • Table 23 Forecast Sales of Analgesics by Category: Value 2010-2015
  • Table 24 Forecast Sales of Analgesics by Category: % Value Growth 2010-2015

Calming and Sleeping in Canada - Category Analysis

HEADLINES

TRENDS

  • In 2010, both volume and value sales of calming and sleeping products grew 7%, reaching C$30 million in current value terms. Demand was primarily bolstered by Canada’s ageing population and a rising rate of sleep deprivation across all ages of Canadians, caused by difficult economic climate, poor diet and hectic lifestyle.

SWITCHES

COMPETITIVE LANDSCAPE

  • GlaxoSmithKline remained in the lead for calming and sleeping products in 2010, with a category value share of 42%. Nytol continues to be one of the best-established and trusted OTC brands available in Canada, and it has a strong presence in retail outlets. However, its value share declined to 37% (from 38%) in 2010 due to health concerns surrounding the product. Industry experts and researchers encouraged patients to first consult their doctor or pharmacist before taking Nytol due to some of its side effects, such as dizziness, drowsiness, dry mouth and thickening of the mucus in the nose and throat, which can be dangerous if the product is taken without caution.

PROSPECTS

  • Over the forecast period, retail sales of calming and sleeping products are projected to grow at a CAGR of 5%, reaching C$38 million in constant value terms by 2015. The continued ageing of the Canadian population, combined with rising levels of anxiety amongst Canadians, will likely drive up demand for calming and sleeping products.

CATEGORY DATA

  • Table 25 Sales of Calming and Sleeping: Value 2005-2010
  • Table 26 Sales of Calming and Sleeping: % Value Growth 2005-2010
  • Table 27 Calming and Sleeping Company Shares by Value 2006-2010
  • Table 28 Calming and Sleeping Brand Shares by Value 2007-2010
  • Table 29 Forecast Sales of Calming and Sleeping: Value 2010-2015
  • Table 30 Forecast Sales of Calming and Sleeping: % Value Growth 2010-2015

Cough, Cold and Allergy (Hay Fever) Remedies in Canada - Category Analysis

HEADLINES

TRENDS

  • In 2010, overall retail sales of cough, cold and allergy (hay fever) remedies grew 2%, reaching C$716 million. Growth was mainly bolstered by increased incidence of allergy symptoms as well as the rising number of Canadians taking preventative self-care medications in light of widespread health concerns over H1N1 flu and other viruses.

SWITCHES

COMPETITIVE LANDSCAPE

  • McNeil Consumer Healthcare continued to lead overall sales of cough, cold and allergy (hay fever) remedies, with a category value share of 22% in 2010. The company’s leading position reflected the strength of its portfolio, which covers antihistamines/allergy remedies (systemic), child-specific allergy remedies, combination products, cough remedies and oral decongestants, and includes trusted and popular brands like Benylin, Tylenol, Reactine, Sudafed, Benadryl and Sinutab. During the review period, however, McNeil Consumer Healthcare saw its category value share decline due to weak performances by categories where the company has a strong presence, most notably cough remedies, where its Benylin brand held the top position with a value share of 28% in 2010.

PROSPECTS

  • Over the forecast period, retail sales of cough, cold and allergy (hay fever) remedies are projected to grow at a CAGR of 2%, reaching C$776 million in 2015. Growth will continue to be driven by rising incidence of allergy symptoms (due to warmer global weather) as well as the rising number of Canadians taking preventative self-care medications in light of widespread health concerns over H1N1 flu and other viruses.

CATEGORY DATA

  • Table 31 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2005-2010
  • Table 32 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2005-2010
  • Table 33 Sales of Decongestants by Category: Value 2005-2010
  • Table 34 Sales of Decongestants by Category: % Value Growth 2005-2010
  • Table 35 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2005-2010
  • Table 36 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2005-2010
  • Table 37 Cough, Cold and Allergy (Hay Fever) Remedies Company Shares by Value 2006-2010
  • Table 38 Cough, Cold and Allergy (Hay Fever) Remedies Brand Shares by Value 2007-2010
  • Table 39 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2010-2015
  • Table 40 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2010-2015

Digestive Remedies in Canada - Category Analysis

HEADLINES

TRENDS

  • Retail sales of digestive remedies registered a solid growth of 3%, reaching current value sales of C$363 million in 2010. The rapidly ageing population in Canada as well as rising incidence of indigestion due to poor diet and widespread sedentary lifestyles have all contributed to the growing demand.

SWITCHES

COMPETITIVE LANDSCAPE

  • Digestive remedies remains highly fragmented, with McNeil Consumer Healthcare in the lead position at a value share of 15% in 2010. The company continued to dominate diarrhoeal remedies, with a value share of nearly 60%, and ranked second in both antiflatulents and H2 blockers thanks to the strength of its Rolaids and Zantac brands respectively. A slight decline in shares of antiflatulents, however, was largely due to its recall of Rolaids products in early 2010 due to uncharacteristic odours that were linked with certain wood pallets used in the transportation and storage of packaging materials.

PROSPECTS

  • Over the forecast period, overall retail sales of digestive remedies are projected to grow at a CAGR of 4%, reaching nearly C$404 million by 2015. Growth in this category will largely be driven by the ageing population of Canada as well as rising incidence of indigestion and other digestive problems due to poor diet and widespread sedentary lifestyles.

CATEGORY DATA

  • Table 41 Sales of Digestive Remedies by Category: Value 2005-2010
  • Table 42 Sales of Digestive Remedies by Category: % Value Growth 2005-2010
  • Table 43 Digestive Remedies Company Shares by Value 2006-2010
  • Table 44 Digestive Remedies Brand Shares by Value 2007-2010
  • Table 45 Forecast Sales of Digestive Remedies by Category: Value 2010-2015
  • Table 46 Forecast Sales of Digestive Remedies by Category: % Value Growth 2010-2015

Ear Care in Canada - Category Analysis

HEADLINES

TRENDS

  • Retail sales of ear care products declined by 1%, reaching C$8 million in current value terms. The weakening performance of the category throughout the review period is largely due to overwhelming preference amongst consumers for professional help regarding earwax removal for fear of worsening symptoms or causing permanent damage. Furthermore, given that the cost of professional earwax removal is covered by the public healthcare system, consumers have generally found OTC ear care products less appealing and consequently, manufacturers have been reluctant to invest in product innovation and marketing efforts.

SWITCHES

COMPETITIVE LANDSCAPE

  • Prestige Brands International Inc continued to lead sales of ear care products with a value share of 15% in 2010. Prestige Brands International Inc was organised in 1999 as a leading manufacturer of personal and household care products, and became part of Prestige Brands Holdings, Inc in 2004 by merging with two other consumer care companies. Within the ear care category, Prestige Brands International Inc is well known for its leading brand, Murine. Under this brand, the company offers ear care products in two formats – ear drops (Murine Ear Drops) and sprays (Murine Earigate).

PROSPECTS

  • Retail sales of ear care products are projected to decline by 2% over the forecast period, reaching C$8 million in 2015. Continued preference for professional help, supported by treatment coverage by the public healthcare system, will likely hinder demand for OTC ear care products across Canada.

CATEGORY DATA

  • Table 47 Sales of Ear Care: Value 2005-2010
  • Table 48 Sales of Ear Care: % Value Growth 2005-2010
  • Table 49 Ear Care Company Shares by Value 2006-2010
  • Table 50 Ear Care Brand Shares by Value 2007-2010
  • Table 51 Forecast Sales of Ear Care: Value 2010-2015
  • Table 52 Forecast Sales of Ear Care: % Value Growth 2010-2015

Emergency Contraception in Canada - Category Analysis

HEADLINES

TRENDS

  • During 2010, retail sales of emergency contraception grew 13% to reach C$22 million in current value terms. Growth was slower compared to previous years of the review period, which saw significant sales growth as a result of greater access to the product (ie without prescription). Sales nonetheless remained strong throughout 2010 due to the declining teen pregnancy rate and growing preference for career over childbearing amongst Canadian women.

COMPETITIVE LANDSCAPE

  • Plan B from Duramed Pharmaceuticals Inc continued to dominate emergency contraception in 2010 with a value share of over 100%.

PROSPECTS

  • Over the forecast period, retail sales of emergency contraception are projected to grow at a CAGR of 10%, reaching C$35 million in 2015. Growth will continue to be driven by the rising sexual education level amongst young women as well as the increasing employment rate amongst Canadian women. As living costs and education levels rise, more women in Canada will likely join the workforce to contribute to household finance, putting childbearing on hold until a later part of their lives. Furthermore, as young women become increasingly aware of health risks associated with unsafe sex, the demand for effective contraception will continue to rise over the forecast period.

CATEGORY DATA

  • Table 53 Sales of Emergency Contraception: Value 2005-2010
  • Table 54 Sales of Emergency Contraception: % Value Growth 2005-2010
  • Table 55 Emergency Contraception Company Shares by Value 2006-2010
  • Table 56 Emergency Contraception Brand Shares by Value 2007-2010
  • Table 57 Forecast Sales of Emergency Contraception: Value 2010-2015
  • Table 58 Forecast Sales of Emergency Contraception: % Value Growth 2010-2015

Eye Care in Canada - Category Analysis

HEADLINES

TRENDS

  • In 2010, total retail sales of eye care products grew 5%, reaching C$98 million in current value terms. Strong growth in demand was bolstered primarily by the ageing population as well as growing use of technological devices that negatively affect vision health.

SWITCHES

COMPETITIVE LANDSCAPE

  • In both allergy and standard eye care, McNeil Consumer Healthcare remained the leading manufacturer with category value shares of 24% and 28%, respectively, in 2010. McNeil Consumer Healthcare, a division of Johnson & Johnson Inc, offers an extensive line of eye care products under its flagship brand, Visine. Visine eye care products claimed the highest value share of 28%, a slight increase from 2009.

PROSPECTS

  • Retail sales of eye care products are projected to grow at a CAGR of 4% over the forecast period to reach almost C$118 million by 2015. Strong growth is anticipated due to Canada’s ageing population as well as rapid advancement of, and reliance on, technology in daily life.

CATEGORY DATA

  • Table 59 Sales of Eye Care by Category: Value 2005-2010
  • Table 60 Sales of Eye Care by Category: % Value Growth 2005-2010
  • Table 61 Standard Eye Care by Type: % Value Breakdown 2007-2010
  • Table 62 Eye Care Company Shares by Value 2006-2010
  • Table 63 Eye Care Brand Shares by Value 2007-2010
  • Table 64 Forecast Sales of Eye Care by Category: Value 2010-2015
  • Table 65 Forecast Sales of Eye Care by Category: % Value Growth 2010-2015

Herbal/Traditional Products in Canada - Category Analysis

HEADLINES

TRENDS

  • Retail sales of herbal/traditional products declined by 1%, reaching current value sales of C$532 million in 2010. Growing public concerns and scepticism surrounding the safety and efficacy of herbal/traditional products, as well as Canada’s strict regulatory framework regarding NHPs, contributed to the falling demand for such products.

COMPETITIVE LANDSCAPE

  • Cadbury Adams Canada Inc (now owned by Kraft Foods) remained the leading manufacturer of herbal/traditional products in 2010 with a value share of 13%. The company’s overall leadership was attributable to the dominance of its Halls brand in medicated confectionery. In 2010, the company claimed a leading value share of 47% of total cough, cold and allergy remedies sales. Natural health products specialist CE Jamieson & Co Ltd ranked second overall with a category value share of 5%. The company held the number one position in herbal/traditional calming and sleeping products and vitamins and dietary supplements, offering a range of products under its Jamieson Natural Sources brand in both categories. Jamieson Natural Sources products continue to be widely distributed in mainstream channels, including parapharmacies/drugstores, as well as healthfood shops.

PROSPECTS

  • Over the forecast period, retail sales of herbal/traditional products are projected to decline to a total of C$527 million by 2015. The regulatory change in the sale and marketing of unlicensed NHPs will likely drive down sales in all categories, with the exception of digestive remedies. As a result of NAPRA’s directive to manufacturers not to sell unlicensed NHPs in early 2010, most of which are waiting for Health Canada approval, most products will remain stuck in warehouses, costing a significant amount of loss within the industry.

CATEGORY DATA

  • Table 66 Sales of Herbal/Traditional Products: Value 2005-2010
  • Table 67 Sales of Herbal/Traditional Products: % Value Growth 2005-2010
  • Table 68 Herbal/Traditional Products Company Shares 2006-2010
  • Table 69 Herbal/Traditional Products Brand Shares 2007-2010
  • Table 70 Forecast Sales of Herbal/Traditional Products: Value 2010-2015
  • Table 71 Forecast Sales of Herbal/Traditional Products: % Value Growth 2010-2015

Medicated Skin Care in Canada - Category Analysis

HEADLINES

TRENDS

  • Medicated skin care grew 2% during 2010, reaching C$372 million in current value terms. Changes in demographic and lifestyle (ie diet, physical activities) trends amongst Canadians have contributed to dermatologic issues, including acne, hair loss and other skin-related irritation problems. Moreover, the relatively high cost of professional care from dermatologists has encouraged the use of OTC medicated skin care products.

SWITCHES

COMPETITIVE LANDSCAPE

  • Medicated skin care remains highly fragmented with McNeil Consumer Healthcare in the lead with a value share of 23% in 2010. The company has an extensive portfolio of skin care products, most notably Benadryl, Polysporin and Rogaine. It had the highest value share of hair loss treatments of 84%, led by its flagship brand, Rogaine. It also held the highest value share of topical allergy remedies/antihistamines of 78%, bolstered by its well-established brand Benadryl. Finally, the company enjoyed its leading position in topical germicidals/antiseptics with a value share of 22%. It has introduced its new Polysporin Poly To Go, which provides convenient infection protection for on-the-go consumers.

PROSPECTS

  • Overall retail sales of medicated skin care products are projected to grow at a CAGR of 2%, reaching C$412 million by 2015. The rapidly ageing population and changing lifestyle trends (ie diet, physical activities) will likely continue to drive demand for medicated skin care. Furthermore, the high cost of professional care from dermatologists will continue to have a positive impact on the development of OTC medicated skin care products.

CATEGORY DATA

  • Table 72 Sales of Medicated Skin Care by Category: Value 2005-2010
  • Table 73 Sales of Medicated Skin Care by Category: % Value Growth 2005-2010
  • Table 74 Acne Treatments by Format: % Value Breakdown 2005-2010
  • Table 75 Medicated Skin Care Company Shares by Value 2006-2010
  • Table 76 Medicated Skin Care Brand Shares by Value 2007-2010
  • Table 77 Acne Treatments Brand Shares by Value 2007-2010
  • Table 78 Hair Loss Treatments Brand Shares by Value 2007-2010
  • Table 79 Forecast Sales of Medicated Skin Care by Category: Value 2010-2015
  • Table 80 Forecast Sales of Medicated Skin Care by Category: % Value Growth 2010-2015

NRT Smoking Cessation Aids in Canada - Category Analysis

HEADLINES

TRENDS

  • During 2010, NRT smoking cessation aids grew 1%, reaching C$135 million in current value terms. Growth was largely bolstered by the declining smoking rate amongst Canadians, rising health awareness, changing societal attitudes towards smoking, and various government initiatives aimed at reducing tobacco consumption. All Canadian provinces now have strict bans on smoking in public places, including foodservice outlets, offices and other workplaces, airports, universities, schools and hospitals. In British Columbia, Nova Scotia, Ontario and New Brunswick, it is also illegal to smoke in cars with passengers under 16 years of age.

SWITCHES

COMPETITIVE LANDSCAPE

  • McNeil Consumer Healthcare remains the leading manufacturer of NRT smoking cessation aid products, claiming a value category share of 88% in 2010, a slight increase from 2009. McNeil Consumer Healthcare is a division of Johnson & Johnson Inc and carries an extensive portfolio of smoking cessation aid products, including its flagship brands Nicorette and Nicoderm.

PROSPECTS

  • Over the forecast period, retail sales of NRT smoking cessation aid products are projected to grow at a CAGR of 1%, reaching C$143 million by 2015. Growing awareness of health risks associated with smoking (ie lung cancer, oral hygiene) as well as changing societal attitudes towards tobacco use will likely bolster efforts to quit smoking amongst Canadian smokers, driving demand for OTC smoking cessation aid products. Furthermore, rising concerns surrounding the safety and efficacy of prescription drugs will likely lead to use of nonprescription OTC brands.

CATEGORY INDICATORS

  • Table 81 Number of Smokers by Gender 2005-2010

CATEGORY DATA

  • Table 82 Sales of NRT Smoking Cessation Aids by Category: Value 2005-2010
  • Table 83 Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2005-2010
  • Table 84 NRT Gum Flavours: % Value Breakdown 2006-2010
  • Table 85 NRT Smoking Cessation Aids Company Shares by Value 2006-2010
  • Table 86 NRT Smoking Cessation Aids Brand Shares by Value 2007-2010
  • Table 87 Forecast Sales of NRT Smoking Cessation Aids by Category: Value 2010-2015
  • Table 88 Forecast Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2010-2015

Sports Nutrition in Canada - Category Analysis

HEADLINES

TRENDS

  • During 2010, retail sales of sports nutrition products grew 3% to reach C$122 million in current value terms. Sports nutrition registered slower growth than in previous years of the review period, largely due to rising concerns over health risks associated with consumption of protein-based drinks. These drinks, sold as ready-to-drink liquids or powders that are often consumed with milk, juice or water, attract not only athletes, but also baby boomers, pregnant women and teenagers looking for a shortcut to boost energy. However, the media have reported rising numbers of incidents of stomach issues and diarrhoea amongst consumers of these products, raising public concerns over their safety and efficacy.

COMPETITIVE LANDSCAPE

  • Weider Nutrition Group (Canada) Ltd continues to lead retail sales of sports nutrition products with a value share of 26% in 2010. Weider sports nutrition products are offered in a variety of formats and pack sizes. They are widely distributed by specialist retailers, but also commonly found in mainstream retail outlets such as those in the parapharmacies/drugstores channel. Distribution via mainstream retail channels helps the company to reach a wider base of consumers than some of its main rivals.

PROSPECTS

  • Retail sales of sports nutrition products are projected to grow at a CAGR of 2% over the forecast period, reaching C$133 million in 2015. Growth is expected to be slower than in the review period due to rising health concerns associated with protein-based drinks as well as growing preference for foods as natural sources of protein and other essential nutrients. According to the latest survey released by Statistics Canada, on a per capita basis, the Canadian diet in 2009 included more fresh fruits and vegetables and fish compared to the previous year.

CATEGORY DATA

  • Summary 13 Sports Nutrition, category rankings 2010
  • Table 89 Sales of Sports Nutrition: Value 2005-2010
  • Table 90 Sales of Sports Nutrition: % Value Growth 2005-2010
  • Table 91 Sports Nutrition By Format: % Value Breakdown 2007-2010
  • Table 92 Sports Nutrition Company Shares 2006-2010
  • Table 93 Sports Nutrition Brand Shares 2007-2010
  • Table 94 Forecast Sales of Sports Nutrition: Value 2010-2015
  • Table 95 Forecast Sales of Sports Nutrition: % Value Growth 2010-2015

Vitamins and Dietary Supplements in Canada - Category Analysis

HEADLINES

TRENDS

  • The year 2010 saw a healthy growth of 4% in current value sales of vitamins and dietary supplements, reaching C$1 billion overall. Strong growth in this category was mainly driven by Canada’s rapidly ageing population as well as rising concerns over deficiencies of certain vitamins and minerals across all ages, increasing the overall demand for vitamins and dietary supplements.

VITAMINS

DIETARY SUPPLEMENTS

COMPETITIVE LANDSCAPE

  • The vitamins and dietary supplements industry remains highly fragmented. However, CE Jamieson & Co Ltd, a private Canadian manufacturer, remained in the lead with a category value share of 22% in 2010. The company’s overall leadership was mainly due to the success of its Jamieson Natural Sources brand, which is present in most vitamins and dietary supplements categories. A well-established company in Canada, CE Jamieson works closely with Health Canada and other regulatory bodies to obtain premarketing approval and drug identification numbers for its products. The company’s share continued to increase during the review period, thanks to the introduction of its FluShield, an echinacea-based herbal medicine designed to fight cold and flu symptoms.

PROSPECTS

  • Over the forecast period, overall sales of vitamins and dietary supplements are projected to grow by CAGR of 3%, reaching C$1 billion in 2015. Relatively modest sales growth is largely due to ongoing decline in a number of herbal products, although overall herbal/traditional vitamins and dietary supplements will see an increase of CAGR 4% totalling C$ 376 million by the end of 2015. The widespread concerns and scepticism surrounding the safety and efficacy of such products as well as Canada’s strict regulatory environment regarding natural health products (NHPs) will likely hamper consumer demand for and product development in this category.

CATEGORY DATA

  • Summary 14 Dietary Supplements: Brand Ranking by Positioning 2010
  • Table 96 Sales of Vitamins and Dietary Supplements by Category: Value 2005-2010
  • Table 97 Sales of Vitamins and Dietary Supplements by Category: % Value Growth 2005-2010
  • Table 98 Dietary Supplements by Positioning 2005-2010
  • Table 99 Vitamins and Dietary Supplements Company Shares by Value 2006-2010
  • Table 100 Vitamins and Dietary Supplements Brand Shares by Value 2007-2010
  • Table 101 Vitamins Brand Shares by Value 2007-2010
  • Table 102 Dietary Supplements Brand Shares by Value 2007-2010
  • Table 103 Forecast Sales of Vitamins and Dietary Supplements by Category: Value 2010-2015
  • Table 104 Forecast Sales of Vitamins and Dietary Supplements by Category: % Value Growth 2010-2015

Weight Management in Canada - Category Analysis

HEADLINES

TRENDS

  • Sales of weight management products grew 4%, reaching C$176 million in 2010 in current value terms. Growth in this category was largely driven by rising incidence of overweight and obesity amongst Canadians. In a study published in 2010 by the Organisation of Economic Cooperation and Development (OECD), 25% of Canadians were considered obese and the rate was expected to rise 5% over the next ten years. Men, in particular, experienced higher risk of obesity than women with two out of three being overweight.

COMPETITIVE LANDSCAPE

  • Unilever Canada Inc remains the leading manufacturer of weight management products with a value share of 59% in 2010. The company is most prevalent in the meal replacement slimming category, in which it held a 73% value share. Its leading brand, Slim Fast, has been successful in helping Canadians structure their meal plans and control their calorie intakes through its 3-2-1 Plan, encouraging them to lead much healthier lifestyles. Given the widespread perception that meal replacement products are an effective and safe means of losing weight, Unilever Canada Inc has enjoyed growing consumer demand for its products.

PROSPECTS

  • Over the forecast period, retail sales of weight management products are projected to grow at a CAGR of 3%, reaching C$206 million in 2015. Rising incidence of, and concerns over, obesity in Canada will remain the primary driver of growth, as indicated by the above-mentioned OECD’s study, which noted that the obesity rate in Canada is expected to rise 5% over the next ten years. As consumers become increasingly aware of health risks associated with overweight and obesity, the demand for weight management products will likely grow over the forecast period.

CATEGORY DATA

  • Table 105 Sales of Weight Management: Value 2005-2010
  • Table 106 Sales of Weight Management: % Value Growth 2005-2010
  • Table 107 Weight Management Company Shares 2006-2010
  • Table 108 Weight Management Brand Shares 2007-2010
  • Table 109 Forecast Sales of Weight Management: Value 2010-2015
  • Table 110 Forecast Sales of Weight Management: % Value Growth 2010-2015

Wound Care in Canada - Category Analysis

HEADLINES

TRENDS

  • During 2010, retail sales of wound care products grew 3%, reaching just over C$103 million in current value terms. Growth was primarily driven by ageing population and the increasing rate of injuries associated with it. British Columbia Injury Research and Prevention Unit studies show that one third of Canadians aged 65 years and over fall once or more each year, resulting in cuts and bruises. Most falls occur at home in the course of usual daily activities.

COMPETITIVE LANDSCAPE

  • Johnson & Johnson (Canada) Inc remained the leading manufacturer of wound care products in Canada with a value share of 41% in 2010. Its flagship brand, Band-Aid, continued to lead sales of sticking plasters/adhesive bandages, claiming a value share of 42%. Band-Aid products are available in a wide range of formats, including plastic, fabric, foam and waterproof, which offer greater comfort and flexibility whilst providing the protection they need.

PROSPECTS

  • Retail sales of wound care products are projected to grow at a CAGR of 2% over the forecast period, reaching just over C$114 million in 2015. The ageing population and rising incidence of injuries associated with age, combined with the growing trend towards active lifestyles and urbanisation, will likely continue to drive consumer demand for wound care products.

CATEGORY DATA

  • Table 111 Sales of Wound Care by Category: Value 2005-2010
  • Table 112 Sales of Wound Care by Category: % Value Growth 2005-2010
  • Table 113 Wound Care Company Shares by Value 2006-2010
  • Table 114 Wound Care Brand Shares by Value 2007-2010
  • Table 115 Forecast Sales of Wound Care by Category: Value 2010-2015
  • Table 116 Forecast Sales of Wound Care by Category: % Value Growth 2010-2015

Segmentation

Segmentation

This market research report includes the following:

  • Consumer Health
    • OTC
      • Adult Mouth Care
      • Analgesics
        • Systemic Analgesics
          • Adult Analgesics
            • Acetaminophen
            • Aspirin
            • Combination Products - Analgesics
            • Diclofenac
            • Dipyrone
            • Ibuprofen
            • Ketoprofen
            • Naproxen
          • Child-Specific Analgesics
            • Child-Specific Acetaminophen
            • Child-Specific Aspirin
            • Child-Specific Combination Products - Analgesics
            • Child-Specific Diclofenac
            • Child-Specific Dipyrone
            • Child-Specific Ibuprofen
            • Child-Specific Ketoprofen
            • Child-Specific Naproxen
        • Topical Analgesics/Anaesthetic
      • Calming and Sleeping
      • Cough, Cold and Allergy (Hay Fever) Remedies
        • Antihistamines/Allergy Remedies (Systemic)
        • Child-Specific Cough, Cold and Allergy Remedies
          • Child-Specific Allergy Remedies
          • Child-Specific Cough/Cold Remedies
        • Combination Products - Cough, Cold and Allergy (Hay Fever) Remedies
        • Cough Remedies
        • Decongestants
          • Nasal Sprays
          • Oral Decongestants
          • Inhalant Decongestants
          • Decongestant Rubs
          • Nasal Decongestant Drops
          • Nasal Decongestant Plasters
        • Medicated Confectionery
        • Pharyngeal Preparations
      • Digestive Remedies
        • Child-Specific Digestive Remedies
          • Child-Specific Diarrhoeal Remedies
          • Child-Specific Indigestion and Heartburn Remedies
          • Child-Specific Laxatives
          • Child-Specific Motion Sickness Remedies
        • Diarrhoeal Remedies
        • IBS Treatments
        • Indigestion and Heartburn Remedies
          • Antacids
          • Antiflatulents
          • Digestive Enzymes
          • H2 Blockers
          • Proton Pump Inhibitors
        • Laxatives
        • Motion Sickness Remedies
      • Ear Care
      • Emergency Contraception
      • Eye Care
        • Allergy Eye Care
        • Standard Eye Care
      • Medicated Skin Care
        • Acne Treatments
        • Medicated Shampoos
        • Topical Antifungals
        • Vaginal Antifungals
        • Hair Loss Treatments
        • Nappy (Diaper) Rash Treatments
        • Antiparasitics/Lice (Head and Body) Treatments
        • Antipruritics
        • Child-Specific Medicated Skin Care
        • Cold Sore Treatments
        • Haemorrhoid Treatments
        • Topical Allergy Remedies/Antihistamines
        • Topical Germicidals/Antiseptics
      • NRT Smoking Cessation Aids
        • NRT Gum
        • NRT Inhalators
        • NRT Lozenges
        • NRT Patches
        • Other NRT
      • OTC Triptans
      • Wound Care
        • First Aid Kits
        • Sticking Plasters/Adhesive Bandages
        • Gauze, Tape and Other Wound Care
    • Sports Nutrition
    • Vitamins and Dietary Supplements
      • Child-Specific Vitamins and Dietary Supplements
      • Dietary Supplements
        • Combination Dietary Supplements
        • Herbal/Traditional Dietary Supplements
          • Combination Herbal/Traditional Dietary Supplements
          • Echinacea
          • Evening Primrose Oil
          • Garlic
          • Ginkgo Biloba
          • Ginseng
          • St John's Wort
          • Other Herbal/Traditional Dietary Supplements
            • Devil's Claw
            • Flaxseed/Linseed
            • Isoflavones
            • Saw Palmetto
            • Other Other Herbal/Traditional Dietary Supplements
        • Non-Herbal Dietary Supplements
          • Calcium Supplements
          • Co-Enzyme Q10
          • Combination Non-Herbal Dietary Supplements
          • Eye Health Supplements
          • Fish Oils
            • Cod Liver Oil
            • Other Fish Oils
          • Glucosamine
          • Mineral Supplements
          • Omega-3-6-9 (Fish and Non-Fish)
          • Probiotic Supplements
          • Protein Powder
          • Royal Jelly
          • Sam-E
          • Other Non-Herbal Dietary Supplements
            • Lecithin
      • Tonics and Bottled Nutritive Drinks
      • Vitamins
        • Multivitamins
        • Single Vitamins
          • Vitamin A
          • Vitamin B
          • Vitamin C
          • Vitamin D
          • Vitamin E
          • Other Single Vitamins
    • Weight Management
      • Meal Replacement Slimming
      • OTC Obesity
      • Slimming Teas
      • Weight Loss Supplements
      • Other Slimming Products
    • Herbal/Traditional Products
      • Herbal/Traditional Analgesics
      • Herbal/Traditional Calming and Sleeping Products
      • Herbal/Traditional Cough, Cold and Allergy (Hay Fever) Remedies
      • Herbal/Traditional Digestive Remedies
      • Herbal/Traditional Medicated Skin Care
      • Herbal/Traditional Medicinal Teas
      • Herbal/Traditional Smoking Cessation Aids
      • Herbal/Traditional Child-Specific Dietary Supplements
      • Herbal/Traditional Dietary Supplements
      • Herbal/Traditional Tonics and Bottled Nutritive Drinks
    • Allergy Care
      • Allergy Eye Care
      • Antihistamines/Allergy Remedies (Systemic)
      • Child-Specific Allergy Remedies
      • Topical Allergy Remedies/Antihistamines
    • Child-Specific Consumer Health
      • Child-Specific Analgesics
        • Child-Specific Acetaminophen
        • Child-Specific Aspirin
        • Child-Specific Combination Products - Analgesics
        • Child-Specific Diclofenac
        • Child-Specific Dipyrone
        • Child-Specific Ibuprofen
        • Child-Specific Ketoprofen
        • Child-Specific Naproxen
      • Child-Specific Cough, Cold and Allergy Remedies
        • Child-Specific Allergy Remedies
        • Child-Specific Cough/Cold Remedies
      • Child-Specific Digestive Remedies
        • Child-Specific Diarrhoeal Remedies
        • Child-Specific Indigestion and Heartburn Remedies
        • Child-Specific Laxatives
        • Child-Specific Motion Sickness Remedies
      • Child-Specific Medicated Skin Care
      • Nappy (Diaper) Rash Treatments
      • Child-Specific Vitamins and Dietary Supplements

Statistics Included

Statistics Included

For each category and subcategory you will receive the following data in Excel format:

From Passport

  • Market sizes
  • Company shares
  • Brand shares
  • Distribution
  • Analysis by format
  • Analysis by positioning
  • Analysis by type
  • Herbal/traditional vs standard
  • Pricing

Market size details:

  • Retail volume
  • Retail volume % growth
  • Retail volume per capita
  • Retail value retail selling price % growth
  • Retail value retail selling price local currency, USD, EUR, GBP, CHF, JPY
  • Retail value retail selling price per capita local currency, USD, EUR, GBP, CHF, JPY
  • Retail value retail selling price real (constant 2008) prices % growth
  • Retail value retail selling price real (constant 2008) prices local currency, USD, EUR, GBP, CHF, JPY
  • Retail value retail selling price real (constant 2008) prices per capita local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price % growth
  • Retail value manufacturer selling price local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price per capita local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price real (constant 2008) prices % growth
  • Retail value manufacturer selling price real (constant 2008) prices local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price real (constant 2008) prices per capita local currency, USD, EUR, GBP, CHF, JPY
  • Retail value retail selling price nominal (current) prices % growth
  • Retail value retail selling price nominal (current) prices local currency, USD, EUR, GBP, CHF, JPY
  • Retail value retail selling price nominal (current) prices per capita local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price nominal (current) prices % growth
  • Retail value manufacturer selling price nominal (current) prices local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price nominal (current) prices per capita local currency, USD, EUR, GBP, CHF, JPY

Methodology

Methodology

Global insight and local knowledge

With 40 years’ experience of developed and emerging markets, Euromonitor International’s research method is built on a unique combination of specialist industry knowledge and in-country research expertise.

This approach is what enables us to achieve our goal of building a market consensus view of size, shape and trends across the full distribution universe of each category. We factor in whichever channels are relevant, from large-scale grocery to direct sellers, from discount stores to local mom-and-pop outlets.

Industry specialists

Each industry we cover is managed by an Industry Manager and team of Industry Analysts who research and report on their specialist categories all year round.

Our collaborative approach to research means that these industry teams are in constant dialogue with industry players and opinion formers. The planning of our research programmes reflects latest market trends and industry events. In completing each update project, this provides invaluable input to the testing, review and finalisation of our data.

The specialist in-house teams bring together findings from all stages of the annual research process. They work closely with in-country analysts, assess and challenge data and exercise final editorial control over the publication of new data and analysis.

Country and regional analysts

Our in-country analyst network is managed by country and regional analysts in our offices around the world. Working closely with each in-country team, the regional research management team ensures that all country researchers are well schooled in best practices, from the information collected in store checks, to the dialogue we build in trade surveys. Our country analysts ensure that national reports explain the data trends and provide clear insights into the local market’s dynamics.

In-country research network

To deliver fresh insights every year in countries all around the world, we believe the strongest approach is to use analysts on the ground. They bring fluency in local language, physical proximity to the best sources, an ability to engage directly with local industry contacts, and an awareness of how the products and services we study are advertised, sold and consumed. These are essential parts of our ability to report incisively on these markets.

Research Methodology

Our research methods

Each Euromonitor International industry report is based on a core set of research techniques:

Desk research

With industry events, corporate activity, trends and new product introductions tracked year round by our industry team, desk research provides a starting point for the in-country research programme. Our in-country researchers will access the following sources:

  • National statistics offices governmental and official sources
  • National and international trade press
  • National and international trade associations
  • Industry study groups and other semi-official sources
  • Company financials and annual reports
  • Broker reports
  • Online databases
  • The financial, business and mainstream press

Accessing sources is only the first step. The ability to interpret and reconcile often conflicting information across multiple sources is a key aspect of the added value we provide.

Store checks

Store checks are an integral part of our methods for product industries. Carried out on the ground across a relevant mix of channels, the information gained provides first-hand insights into the products we are researching, specifically:

  • Place: We track products in all relevant channels, selective and mass, store and non-store
  • Product: What are innovations in products, pack sizes and formats?
  • Price: What are brand price variations across channels, how do private label’s prices compare to those of branded goods?
  • Promotion: What are marketing and merchandising trends, offers, discounts and tie-ins?

Findings are cross-referenced with brand share data analysis. The results, combined with the findings of desk research, provide a strong basis for identifying key areas of questioning to take forward into our trade survey.

Trade survey

Interaction with global players at corporate HQ and regional levels is complemented by unique local data and insights from our in-country trade surveys around the world. Through the high profile of the Euromonitor International brand, we are able to talk directly to a wide range of sources and therefore inform our analysis with the knowledge and opinions of the leading operators in the market.

Trade surveys allow us to:

  • Fill gaps in available published data per company
  • Generate a consensus view of the size, structure and strategic direction of the category
  • Access year-in-progress data where published sources are out of date
  • Evaluate the experts’ views on current trends and market developments

In building our composite industry view, we engage with a variety of personnel in key players at all points of the supply chain: materials suppliers, manufacturers, distributors, retailers and service operators. We also interview desk research sources: industry associations; study groups; and third party observers from the trade and financial press.

Our objective is to engage in conversation with trade sources in which we exchange ideas and views on the industry, sharing our work-in-progress findings on supply/demand dynamics and potential. This dialogue enhances both parties’ understanding of the local market. The scope and reach of our trade survey also serves to eliminate bias (intentional and unintentional) from any single source.

Company analysis

At a global level, our company research combines our mix of industry interaction and use of secondary sources such as annual accounts, broker reports, financial press and databases. From a data perspective, the aim is to build “top-down” estimates of major players’ total global and regional sales.

At a country level, in line with local reporting requirements, we access annual accounts, national-specific company databases and local company websites. These are all invaluable sources as we build a view of each domestic player’s size and position within very specific categories of the industry.

Forecasts

Data projections and future performance analysis are key elements of Euromonitor International’s market intelligence. Working with historic trends of 15 years or more, a key aspect of our trade survey is to engage industry insider views of the next five years. Will volumes maintain their historic trend? Will price increases or falls of recent years continue, accelerate or slow down? Will increasing demand for one product cannibalise sales of another?

Forecasts represent many of the essential conclusions we have reached about the current state of the market, how it works and how it behaves under different macro and micro conditions. Our written analysis will state the assumptions and the trade opinion behind whether our predictions are optimistic or pessimistic, so that clients can use our statistical forecasts with confidence.

Data validation

All data is subjected to an exhaustive review process, at country, regional and global levels.

The interpretation and review of sources and data inputs forms a central part of the collaboration between industry teams and country researchers. Numbers are delivered to regional and global offices with an audit trail of sources and calculations to allow for a thorough evaluation of data sense and integrity.

Upon completion of the country review phase, data is then reviewed on a comparative basis at regional and then at a global level. Comparative checks are carried out on per capita consumption and spending levels, growth rates, patterns of category and subcategory breakdowns and distribution of sales by channel. Top-down estimates are reviewed against bottom-up regional and global market and company sales totals.

Where marked differences are seen between proximate country markets or ones at similar developmental levels, supplementary research is conducted in the relevant countries to confirm and/or amend those findings. This process ensures international comparability across the database, that consistent category and subcategory definitions have been used and that all data has been correctly tested. We make sure that possible discrepancies between different published sources have been reconciled and that our interpretation of opinion and expectation from each country’s trade sources has been applied to form a coherent international pattern.

Market analysis

Another integral part of all our research programmes is that all Euromonitor International data is accompanied by clear written analysis. From a research perspective, this explains and substantiates data findings. From a client perspective, this offers unique insights into local consumption trends, routes to market, brand preferences, channel dynamics and future trends.

Our country level analysis also provides invaluable input into the ability of our central industry specialist teams to marry local insights with strategic conclusions on the direction of the market regionally and globally.

my pages

Want to find out more about this report?

RELATED

Future Demographic

Country Report

Consumer Lifestyle

Country Report